Addiction Toxicology Case Conference - March 2024
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
Chemsex
Case 1: Getting "handsy" at the Gas Station
Case 2: Trench Coats, Poppers & Sildenafil in the Back of the Adult Book Store
Learner Objective 1: Define "chemsex" and common substances used during this activity.
Learner Objective 2: Discuss the role of harm reduction in working with patients involved in Chemsex.
Panelists:
Kelly S. Ramsey, MD, MPH, MA, FACP, DFASAM, Addiction Medicine and Harm Reduction Consultant
Rachel Gorodetsky, PharmD, Assistant Professor, D'Youville School of Pharmacy; Consulting Clinical Toxicologist, University of Rochester Medical Center and Upstate New York Poison Center, Rochester, NY
Moderators:
Timothy J. Wiegand, MD, FACMT, DFASAM, Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY
Gloria J. Baciewicz, MD, Addiction Psycharcist, Strong Recovery; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is open to the public.
Continuing Education credits are available for this activity! Click here for more info.
Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)
Director of Addiction Medicine and Addiction Medicine Consults
University of Rochester Medical Center
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
Gloria Baciewicz, MD (Moderator)
Addiction Psychiatrist
Strong Recovery
Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.
Rachel Gorodetsky, PharmD, DABAT, FAACT
Clinical Associate Professor, D'Youville School of Pharmacy
Consulting Clinical Toxicologist, University of Rochester Medical Center and Upstate New York Poison Center
Dr. Gorodetsky is a Clinical Associate Professor at D’Youville College School of Pharmacy and holds faculty appointments in the Departments of Emergency Medicine at both the University of Rochester Medical Center and SUNY Upstate Medical Center and she is a consultant for the Upstate New York Poison Center. Through these positions, she is active in direct patient care and in the teaching and training of both pharmacy and medical students, residents, and fellows. She completed her PharmD at Albany College of Pharmacy and Health Sciences in 2009, followed by a PGY1 pharmacy practice residency at Saint Francis Hospital and Medical Center in Hartford, CT, and a fellowship in clinical toxicology at the Georgia Poison Center in Atlanta, GA. She achieved the status of Diplomate of the American Board of Applied Toxicology (DABAT) in 2014.
Kelly S. Ramsey, MD, MPH, MA, FACP, DFASAM
Addiction Medicine and Harm Reduction Consultant
Kelly S. Ramsey, MD, MPH, MA, FACP, FASAM is a board certified internal medicine and addiction medicine physician who has treated substance use disorder since 2004. She worked as Medical Director of an academic center-based OTP in the South Bronx before working for nearly a decade for a large FQHC in the Hudson Valley where she created and grew a MAT program for OUD and AUD to 10 sites and 1500 patients. Most recently, Dr. Ramsey worked as the Chief of Medical Services at the NYS Office of Addiction Services and Supports (OASAS). Dr. Ramsey currently works as an Addiction Medicine and Harm Reduction consultant as well as providing clinical care in addiction medicine. She has provided expert advice to the New York State Department of Health AIDS Institute, serving on numerous committees for about 15 years, proving expertise in addiction medicine, harm reduction, HIV care, and HCV care. Dr. Ramsey was the recipient of the New York State Commissioner’s Special Recognition Award for contributions to drug user health in NYS in December 2018. Dr. Ramsey was the Distinguished Contributions to Behavioral Medicine Award Recipient, awarded by the American College of Physicians (ACP)in April 2023. Dr. Ramsey was awarded the Case Western Reserve University School of Medicine Special Medical Alumni Board Award in October 2023. Dr. Ramsey is the President for the NYSAM BOD. In addition, she currently serves as Region I Director on the ASAM Board of Directors.
Continuing Education
Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live virtual activity and enduring activity material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.
Nurses
Credit being awarded:1.25 ANCC contact hours.
Commercial Support
There is no commercial support for this activity.
Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.
Kelly S. Ramsay, MD, Faculty: has nothing to disclose.
Rachel Gorodetsky, PhD, Faculty: has nothing to disclose.
ACMT Staff and Planners: have nothing to disclose.
Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner/Reviewer: has nothing to disclose.
Michele Bielarski, RN, Nurse Planner/Reviewer: has nothing to disclose.
AKH Planners and Reviewers: have nothing to disclose.
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.
Key:
Complete
Next
Failed
Available
Locked